Huang, Jing
Gong, Qian
Li, Qingshu
Xiao, Ming
Li, Ming
Zhang, Shuxian
Wang, Yalan
Tang, Yi
Funding for this research was provided by:
Smart medicine project of Chongqing Medical University (ZHYX2019014, ZHYX2019014, ZHYX2019014, ZHYX2019014, ZHYX2019014, ZHYX2019014, ZHYX2019014, ZHYX2019014)
Open Research Projects of the Key Laboratory of Tumor Immunopathology, Ministry of Education (2021jsz707, 2021jsz707, 2021jsz707, 2021jsz707, 2021jsz707, 2021jsz707, 2021jsz707, 2021jsz707)
Future Medical Youth Innovation team support program of Chongqing Medical University (W0096, W0096, W0096, W0096, W0096, W0096, W0096, W0096)
Article History
Received: 1 November 2024
Accepted: 9 July 2025
First Online: 4 August 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, reviewed and approved by Medical Research Ethics Review Committee of the First Affiliated Hospital of Chongqing Medical University (Number 2024-190-01). The analysis used anonymous clinical data obtained after all the participants agreed to treatment by written consent, so patients were not required to give informed consent for the study.
: Not applicable.
: The authors declare no competing interests.